vs
趣店（HTT）与Lipocine Inc.（LPCN）财务数据对比。点击上方公司名可切换其他公司
Lipocine Inc.的季度营收约是趣店的1.1倍（$1.1M vs $1.1M）
趣店集团是中国本土金融科技服务提供商，核心业务涵盖小额消费信贷解决方案输出、风险管理技术服务及相关数字金融产品供应，主要服务国内广大年轻消费群体，业务布局集中于中国内地市场。
Lipocine Inc是一家处于临床阶段的生物制药企业，专注于激素相关疗法的研发，核心管线覆盖男性健康、女性健康及肝病领域的未满足医疗需求，主要运营与市场布局集中在美国，致力于开发口服制剂以提升患者治疗体验。
HTT vs LPCN — 直观对比
营收规模更大
LPCN
是对方的1.1倍
$1.1M
损益表 — Q3 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $1.1M |
| 净利润 | $2.6M | — |
| 毛利率 | 11.1% | — |
| 营业利润率 | -121.7% | — |
| 净利率 | 239.8% | — |
| 营收同比 | — | -67.2% |
| 净利润同比 | — | -233.0% |
| 每股收益（稀释后） | $0.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTTLPCN
| Q4 25 | — | $1.1M | ||
| Q3 24 | $1.1M | $0 | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $1.1M | $7.6M | ||
| Q3 23 | $559.9K | — | ||
| Q3 22 | $2.1M | — | ||
| Q2 22 | $2.2M | — | ||
| Q1 22 | $4.4M | — |
净利润HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | $2.6M | $-2.2M | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $-1.4M | $3.5M | ||
| Q3 23 | $-3.4M | — | ||
| Q3 22 | $-12.6M | — | ||
| Q2 22 | $-1.3M | — | ||
| Q1 22 | $-3.1M | — |
毛利率HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 13.3% | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 61.0% | — | ||
| Q1 22 | 84.1% | — |
营业利润率HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | -121.7% | — | ||
| Q2 24 | -107.6% | — | ||
| Q1 24 | -129.9% | 42.3% | ||
| Q3 23 | -340.6% | — | ||
| Q3 22 | -272.1% | — | ||
| Q2 22 | -27.8% | — | ||
| Q1 22 | -32.9% | — |
净利率HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | 239.8% | — | ||
| Q2 24 | 187.1% | — | ||
| Q1 24 | -131.8% | 46.1% | ||
| Q3 23 | -612.3% | — | ||
| Q3 22 | -588.2% | — | ||
| Q2 22 | -58.1% | — | ||
| Q1 22 | -70.8% | — |
每股收益（稀释后）HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | $0.01 | $-0.44 | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.01 | $0.66 | ||
| Q3 23 | $-0.02 | — | ||
| Q3 22 | $-0.05 | — | ||
| Q2 22 | $-0.01 | — | ||
| Q1 22 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $104.9M | $5.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $225.2M | $14.5M |
| 总资产 | $246.8M | $17.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HTTLPCN
| Q4 25 | — | $5.2M | ||
| Q3 24 | $104.9M | $3.7M | ||
| Q2 24 | $112.8M | — | ||
| Q1 24 | $140.6M | $3.1M | ||
| Q3 23 | $183.4M | — | ||
| Q3 22 | $154.1M | — | ||
| Q2 22 | $168.3M | — | ||
| Q1 22 | $180.3M | — |
总债务HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | $521.5K | — | ||
| Q1 22 | — | — |
股东权益HTTLPCN
| Q4 25 | — | $14.5M | ||
| Q3 24 | $225.2M | $19.1M | ||
| Q2 24 | $217.5M | — | ||
| Q1 24 | $218.9M | $24.0M | ||
| Q3 23 | $226.0M | — | ||
| Q3 22 | $225.5M | — | ||
| Q2 22 | $253.0M | — | ||
| Q1 22 | $269.4M | — |
总资产HTTLPCN
| Q4 25 | — | $17.0M | ||
| Q3 24 | $246.8M | $20.7M | ||
| Q2 24 | $227.9M | — | ||
| Q1 24 | $234.9M | $25.4M | ||
| Q3 23 | $239.4M | — | ||
| Q3 22 | $249.6M | — | ||
| Q2 22 | $283.4M | — | ||
| Q1 22 | $296.3M | — |
负债/权益比HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 0.00× | — | ||
| Q1 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-9.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HTTLPCN
| Q4 25 | — | $-9.8M | ||
| Q3 24 | — | $-2.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.4M | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
现金转化率HTTLPCN
| Q4 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.69× | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
